The diabetes cardiovascular outcomes trials and racial and ethnic minority enrollment: impact, barriers, and potential solutions
Type 2 diabetes (T2D) affects millions of individuals worldwide and is a well-documented risk factor for cardiovascular (CV) disease and chronic kidney disease, both of which are leading causes of mortality. Racial and ethnic minority groups in the US, including but not limited to Hispanic/Latino, n...
Saved in:
Main Authors: | Matthew R. Sinclair (Author), Mariam Ardehali (Author), Clarissa J. Diamantidis (Author), Leonor Corsino (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Improving clinical trial enrollment in minority racial and ethnic patients with gynecologic malignancy
by: Olivia D. Lara, et al.
Published: (2024) -
Improving the enrollment of women and racially/ethnically diverse populations in cardiovascular clinical trials: An ASPC practice statement
by: Erin D. Michos, et al.
Published: (2021) -
Cardiovascular disease in racial/ethnic minority populations: illness burden and overview of community-based interventions
by: Brandon Muncan
Published: (2018) -
Increasing Latinx representation in the US medical schools: A top-ranked medical school's experience
by: Leonor Corsino, et al.
Published: (2022) -
Ethnic/racial minorities' and migrants' access to COVID-19 vaccines: A systematic review of barriers and facilitators
by: Mohammed Abba-Aji, et al.
Published: (2022)